Sarepta Therapeutics
SRPT
SRPT
364 hedge funds and large institutions have $7.21B invested in Sarepta Therapeutics in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 124 increasing their positions, 129 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
24% less capital invested
Capital invested by funds: $9.51B → $7.21B (-$2.29B)
28% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 71
Holders
364
Holding in Top 10
8
Calls
$172M
Puts
$209M
Top Buyers
| 1 | +$143M | |
| 2 | +$91.7M | |
| 3 | +$45.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$34.6M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$34.2M |
Top Sellers
| 1 | -$160M | |
| 2 | -$74.6M | |
| 3 | -$71M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$44.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$29M |